Replies to post #393384 on Anavex Life Sciences Corp (AVXL)

[mike_dotcom]

I think the part that's understood is "will continue to make its way through clinical trials." In other words, many more years of testing to see if it really works.

[BioMojo]

Agreed Falcon!! Sure could have added a few more details, but we all know they don't want to upset the BP apple cart.

[Kittykitty]

I agree that is disappointing that a journal as highly regarded makes such mistakes, but when I was reviewing research we found plenty of mistakes in such journals. The good news is that AVXL was mentioned.

[Foosfund]

Falconer: I find it interesting that Nature Magazine, in highlighting various scientific breakthroughs to keep an eye on in 2023, mentioned only two in the “hot” field of Alzheimer’s disease — Biogen’s Lecanemab and Anavex’s Blaracmesine.

Could it be that the expected Peer Review is under review at Nature?